(Q59586296)
Statements
Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial (English)
Andrzej Mackiewicz
Antoni Ribas
Keith Flaherty
Jacob Schachter
Reinhard Dummer
Dirk Schadendorf
Boguslawa Karaszewska
Jeffrey J Legos
Bijoyesh Mookerjee
Mayur M Amonkar
Diane Opatt McDowell
Axel Hauschild
Florent Grange
Mikhail Lichinitser
Pascal Wolter
Paul Nathan
Peng Sun
Caroline Robert